Yra.no
company

PHARMA NORDIC AS

6002 Ã…LESUND

Overview

Finances

Roles & Owners
Share Ownership
Return on Equity
−2 797,18 %
Current Ratio
0,8
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue85 000
Net Income−1 986 000
Total Assets2 487 000
Total Equity71 000
Income (NOK)2022
Revenue85 000
Expenditure2 608 000
Operating Profit−2 524 000
Financial Income1 000
Financial Costs14 000
Financial Balance−13 000
Earnings Before Tax−2 536 000
Tax−551 000
Net Income−1 986 000
Balance (NOK)2022
Total Fixed Assets551 000
Total Current Assets1 936 000
Total Assets2 487 000
Total Retained Equity−1 986 000
Total Equity71 000
Total Long-Term Debt0
Total Current Debt2 416 000
Total Equity and Debt2 487 000
Cash flow (NOK)2022
Sales Income85 000
Other Income0
Revenue85 000
Cost of Goods Sold46 000
Salary Costs0
Depreciation0
Impairment0
Expenditure2 608 000
Operating Profit−2 524 000
Financial Income1 000
Financial Costs14 000
Financial Balance−13 000
Dividends0
Net Income−1 986 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets551 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets551 000
Stock657 000
Total Investments0
Cash, Bank1 094 000
Total Current Assets1 936 000
Total Assets2 487 000
Total Equity71 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors256 000
Unpaid Taxes0
Dividends0
Other Current Debt2 161 000
Total Current Debt2 416 000
Total Equity and Debt2 487 000
Financial indicators2022
Return on Equity−2 797,18 %
Debt-to-Equity Ratio0
Operating Profit Margin−2 969,41 %
Current Ratio0,8
Quick Ratio1,1
Equity Ratio0,03
Gross Profit Margin45,88 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English